Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome

Archives of Pediatrics and Adolescent Medicine

Volumn 160, Issue 7, 2006, Pages 686-690

  Baer, Aryeh Z ^a   Rubin, Lorry G ^a,b   Shapiro, Craig A ^a   Sood, Sunil K ^a   Rajan, Sujatha ^a   Shapir, Yehuda ^a   Romano, Angela ^a   Bierman, Fredrick Z ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; ECHOCARDIOGRAPHY; FEMALE; HEART INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

CHILD, PRESCHOOL; CORONARY ANEURYSM; CORONARY VESSELS; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33745700145     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.160.7.686     Document Type: Article

References (14)

1. Newburger JW, Takahashi M, Gerber MA, et al; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2004;110:2747-2771.
2. Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease. Pediatrics. 1999;104:e10.
3. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. West J Med. 1995;162:322-327.
4. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
5. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
6. Pallotto E, Shulman ST, Rowley AH, Goldberg C. Does the treatment of Kawasaki disease within the first 7 days of illness improve the long-term outcome compared to later (8-10th day) treatment? In: Kato H, ed. Kawasaki Disease: Proceedings of the Fifth International Kawasaki Disease Symposium, Fukuoka, Japan. Amsterdam, the Netherlands: Elsevier; 1995:305-309.
7. Tse SM, Silverman ED, McCrindle BW, Yeung RS. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr. 2002;140:450-455.
8. Barron KS, Murphy DJ, Silverman ED, Ruttenberg HD, Wright GB, Franklin W. Treatment of Kawasaki syndrome. J Pediatr. 1990;117:638-644.
9. De Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254-258.
10. Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int. 2002;44:1-4.
11. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med. 2000;154:694-699.
12. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection. Arch Pediatr Adolesc Med. 2000;154:453-456.
13. Miura M, Okhi H, Tsuchihashi T, Yamagishi H, Katada Y, Yamada K. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin. Arch Dis Child. 2004;89:776-780.
14. Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005;116:e89-e93.